Clinical Trials Browser

OTHER × Interventional × Breakthrough Pain × Clear all

NCT05053308 2023-08-07

Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid Requirement

Phase NA Withdrawn

Cancer Pain, Breakthrough Pain

NCT03809455 2020-04-22

FARADI

Phase 2 Withdrawn

Breakthrough Pain

NCT02869321 2019-05-13

ANTALGIP

Phase 4 Completed

Head and Neck Neoplasms, Breakthrough Pain

NCT00125294 2017-09-25

Sublingual Methadone for the Management of Cancer Breakthrough Pain

Phase 1 Completed

Cancer Pain, Neoplasms, Pain, Breakthrough Pain